Ling-yun Zhou
Tongzipo Road 138
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Differential fracture risk among proton pump inhibitors in older adults: evidence network and pharmacovigilance validation.
Journal: Frontiers in pharmacology
Published: March 21, 2026
Glycyrrhizin alleviates contrast-induced acute kidney injury via inhibiting HMGB1-mediated renal tubular epithelial cells ferroptosis.
Journal: Renal failure
Published: August 31, 2025
Hypoalbuminemia and cisplatin-induced acute kidney injury.
Journal: Frontiers in pharmacology
Published: October 13, 2024
Layer-by-Layer Assembly of Renal-Targeted Polymeric Nanoparticles for Robust Arginase-2 Knockdown and Contrast-Induced Acute Kidney Injury Prevention.
Journal: Advanced healthcare materials
Published: December 31, 2023
Identification and validation of hub genes in drug induced acute kidney injury basing on integrated transcriptomic analysis.
Journal: Frontiers in immunology
Published: December 17, 2022
Hydrogel and nanoparticle carriers for kidney disease therapy: trends and recent advancements.
Journal: Progress in biomedical engineering (Bristol, England)
Published: November 20, 2021
Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials.
Journal: Frontiers in pharmacology
Published: September 25, 2021
New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis.
Journal: Frontiers in pharmacology
Published: September 13, 2021
Association Between Initiation, Intensity, and Cessation of Smoking and Mortality Risk in Patients With Cardiovascular Disease: A Cohort Study.
Journal: Frontiers in cardiovascular medicine
Published: June 21, 2021
A Novel Creatinine-Based Equation to Estimate Glomerular Filtration Rate in Chinese Population With Chronic Kidney Disease: Implications for DOACs Dosing in Atrial Fibrillation Patients.
Journal: Frontiers in pharmacology
Published: October 10, 2020
Last Updated: 09/26/2026